Last reviewed · How we verify
Hypercortisolism
Approved treatments
- Desopan · Bioenvision
- Isturisa · Recordati
Isturisa blocks the production of cortisol in the adrenal glands by inhibiting the cytochrome P450 11B2 enzyme. - Signifor · Recordati
Signifor works by binding to somatostatin receptors on the surface of cells, mimicking the natural hormone somatostatin to reduce cortisol production. - Nizoral · Johnson & Johnson (Janssen)
- Signifor · University Hospital Heidelberg
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypercortisolism patent landscape — cliff calendar, originator estates, attackable patents
- Hypercortisolism treatment landscape brief
- Hypercortisolism treatment updates RSS
Frequently asked questions about Hypercortisolism
What drugs treat Hypercortisolism?
Tracked treatments include Desopan, Isturisa, Signifor, Nizoral.
What is the treatment for Hypercortisolism?
Standard treatment for Hypercortisolism includes Desopan, Isturisa, Signifor, Nizoral. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypercortisolism patent cliff · Hypercortisolism CI report
- Treatment: Desopan · Bioenvision
- Treatment: Isturisa · Recordati
- Treatment: Signifor · Recordati
- Treatment: Nizoral · Johnson & Johnson (Janssen)
- Treatment: Signifor · University Hospital Heidelberg
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing